Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is APIXABAN, with a corresponding US DMF Number 30060.
Remarkably, this DMF maintains an Active status since its submission on December 31, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 13, 2016, and payment made on March 10, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II